Direct Rx — FDA Class II (D-0617-2026)

Direct Rx is recalling 263 bottles of their drug due to CGMP deviations. The recall is prompted by the presence of N-nitroso-d. This action affects products distributed from their facility at 94 Worldwide Dr, Georgia.

• •Direct Rx is recalling 263 bottles of their drug.
• •The recall is due to contamination with N-nitroso-d.
• •This action is classified as a Class II recall.
• •Consumers should check their medicine cabinets for this product.

Consumers who purchased this drug should stop using it and return it. The recall affects 263 bottles due to contamination.